Literature DB >> 15539120

Pre-existing renal failure doubles 30-day mortality after heart transplantation.

Maria E Ostermann1, Chris A Rogers, Imran Saeed, Stephen R Nelson, Andrew J Murday.   

Abstract

BACKGROUND: Survival after cardiac transplantation has not changed over the last 10 years. Our objective was to identify risk factors for 30-day mortality after cardiac transplantation with particular reference to focusing on the impact of pre-existing renal dysfunction.
METHODS: We analyzed the data of all 1,180 patients who received a first heart transplant in the 8 adult transplant centers in the United Kingdom between April 1996 and March 2002 using the UK Cardiothoracic Transplant Audit database. Renal function at registration and transplantation was determined by calculation of creatinine clearance (CrCl) according to the Cockcroft-Gault formula.
RESULTS: Multivariate analysis showed that ventilator dependence pre-transplantation and cold ischemia time >4 hours had the highest association with 30-day mortality, followed by CrCl </=50 ml/min. Patients with a CrCl </=50 ml/min on day of transplantation had a significantly higher 30-day mortality compared to patients with CrCl >50 ml/min (19.7% vs 9.5%; p < 0.01). The change in CrCl between registration and transplantation was not related to mean CrCl or waiting time. In 67 of the patients with a CrCl >50 ml/min at registration, CrCl was reduced to </=50 ml/min on day of transplantation (30-day mortality 16.7%).
CONCLUSIONS: Pre-operative CrCl </=50 ml/min doubles the risk of death within 30 days after cardiac transplantation. Patients considered for cardiac transplantation should undergo regular measurement of renal function so that a more accurate risk-benefit assessment can be made.

Entities:  

Mesh:

Year:  2004        PMID: 15539120     DOI: 10.1016/j.healun.2003.09.006

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  4 in total

1.  Long-term outcomes of simultaneous heart and kidney transplantation in pediatric recipients.

Authors:  Patricia L Weng; Juan Carlos Alejos; Nancy Halnon; Qiuheng Zhang; Elaine F Reed; Eileen Tsai Chambers
Journal:  Pediatr Transplant       Date:  2017-07-20

2.  Induction Immunosuppression and Renal Outcomes in Adult Heart Transplantation.

Authors:  Carlos E Diaz-Castrillon; Lauren V Huckaby; Gavin Hickey; Ibrahim Sultan; Arman Kilic
Journal:  J Surg Res       Date:  2020-12-02       Impact factor: 2.417

3.  Heart-kidney listing is better than isolated heart listing for pediatric heart transplant candidates with significant renal insufficiency.

Authors:  Alia Dani; Nina Price; Karthik Thangappan; Thomas D Ryan; David K Hooper; David S Cooper; David G Lehenbauer; Clifford Chin; Farhan Zafar; David L S Morales
Journal:  J Thorac Cardiovasc Surg       Date:  2022-03-01       Impact factor: 6.439

4.  Heart Retransplant Recipients Have Better Survival With Concurrent Kidney Transplant Than With Heart Retransplant Alone.

Authors:  Jill Savla; Kimberly Y Lin; Madhura Pradhan; Rebecca L Ruebner; Rachel S Rogers; Somaly S Haskins; Anjali T Owens; Peter Abt; J William Gaynor; Robert E Shaddy; Joseph W Rossano
Journal:  J Am Heart Assoc       Date:  2015-12-11       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.